Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) and DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, profitability, valuation and earnings.
Valuation and Earnings
This table compares Tandem Diabetes Care and DENTSPLY SIRONA”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tandem Diabetes Care | $1.04 billion | 1.30 | -$204.71 million | ($0.93) | -21.00 |
| DENTSPLY SIRONA | $3.64 billion | 0.60 | -$598.00 million | ($2.75) | -3.96 |
Volatility and Risk
Tandem Diabetes Care has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Tandem Diabetes Care and DENTSPLY SIRONA, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tandem Diabetes Care | 1 | 11 | 10 | 1 | 2.48 |
| DENTSPLY SIRONA | 3 | 9 | 3 | 0 | 2.00 |
Tandem Diabetes Care currently has a consensus target price of $29.34, suggesting a potential upside of 50.25%. DENTSPLY SIRONA has a consensus target price of $13.54, suggesting a potential upside of 24.19%. Given Tandem Diabetes Care’s stronger consensus rating and higher probable upside, analysts plainly believe Tandem Diabetes Care is more favorable than DENTSPLY SIRONA.
Insider and Institutional Ownership
95.7% of DENTSPLY SIRONA shares are held by institutional investors. 2.1% of Tandem Diabetes Care shares are held by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Tandem Diabetes Care and DENTSPLY SIRONA’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tandem Diabetes Care | -6.08% | -45.97% | -6.23% |
| DENTSPLY SIRONA | -14.99% | 20.84% | 5.32% |
Summary
Tandem Diabetes Care beats DENTSPLY SIRONA on 10 of the 15 factors compared between the two stocks.
About Tandem Diabetes Care
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina
Receive News & Ratings for Tandem Diabetes Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tandem Diabetes Care and related companies with MarketBeat.com's FREE daily email newsletter.
